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Abstract
OBJECTIVE—To generate recommendations for framing messages to promote HPV
vaccination, specifically for African American adolescents and their parents who have not yet
made a decision about the vaccine (the “Undecided” market segment).
METHODS—Focus groups and interviews were conducted with African American girls ages 11–
18 (N=34) and their mothers (N=31), broken into market segments based on daughter’s
vaccination status and mother’s intent to vaccinate.
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RESULTS—Findings suggested that the HPV vaccine should be presented to “Undecided”
mothers and adolescents as a routine vaccine (just like other vaccines) that helps prevent cancer.
Within the “Undecided” segment, we identified two sub-segments based on barriers to HPV
vaccination and degree of reluctance. The “Undecided/Ready If Offered” segment would easily
accept HPV vaccine if given the opportunity, with basic information and a healthcare provider
recommendation. The “Undecided/Skeptical” segment would need more in-depth information to
allay concerns about vaccine safety, mistrust of drug companies, and recommended age. Some
mothers and girls had the erroneous perception that girls do not need the vaccine until they
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become sexually active. African American adolescents and their mothers overwhelmingly thought
campaigns should target both girls and boys for HPV vaccination. In addition, campaigns and
messages may need to be tailored for pre-teens (ages 9–12) versus teens (ages 13–18) and their
parents.
CONCLUSIONS—Findings pointed to the need to “normalize” the perception of HPV vaccine
as just another routine vaccine (e.g., part of pre-teen vaccine package). Findings can inform social
marketing campaigns targeting Undecided or ethnically diverse families.
Keywords
HPV vaccine; African Americans; social marketing; formative research

INTRODUCTION
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African American women have higher rates of cervical cancer incidence and mortality than
white women, despite widespread cervical cancer screening in the United States (1–3). In
2010, the age-adjusted incidence of cervical cancer was 6.5/100,000 for White women
compared to 8.1/100,000 for African American women. Mortality rates (per 100,000
women) were 2.1 and 3.9, and overall 5-year survival for all stages of cervical cancer was
71% and 63% for White women and African American women, respectively (2). Persistent
infection with genital human papillomavirus (HPV) types 16 and 18 causes 70% of cervical
cancers (4) and 86–95% of HPV-associated cancers of the oropharynx, anus, vagina, vulva
and penis (5,6). Since 2006, the FDA has approved two prophylactics for females to prevent
infection with HPV-16/18, and in 2010, one of them was also approved for use in males.
These vaccines are nearly 100% efficacious in preventing HPV-16/18 associated cervical,
vaginal, and vulvar precancers in women and highly efficacious for preventing penile
precancers in men (6–8). Thus, HPV vaccination is an important strategy to lower mortality
from cervical cancer and other HPV-associated cancers.
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The Centers for Disease Control and Prevention (CDC) and the Advisory Committee on
Immunization Practices recommend routine HPV vaccination for females and, also since
2011, for males at 11 or 12 years of age, as well as “catch-up” vaccination of up to the age
of 26 years (females) and 21 years (males) (9,10). HPV vaccine consists of three doses
across six months and is available for free to all adolescents ages 9 through 18 under private
insurance, Medicaid and/or the Vaccines for Children (VFC) program. As of 2011, 53.3% of
girls and 8.3% of boys aged 13–17 years in the U.S. started the HPV vaccine series, while
only 34.8% of girls and 1.8% of boys completed all three doses (11). In addition, HPV
vaccine-series completion was lower among African American girls than white girls, with
60.8% versus 74.8% completion among girls who started the series more than 6 months
prior to the interview date (reliable completion data by race are not available for boys).
Another study found that white adolescents were twice as likely to complete the vaccination
schedule on time compared with their African American counterparts, and adolescents with
private insurance were 31% more likely compared to those with public insurance (12).
According to Dissemination of Innovations Theory (13), new innovations (e.g., new
vaccines) are typically adopted by and benefit socially advantaged groups more rapidly. In
other words, over time, increases in full utilization of HPV vaccine and declines in cervical
cancer incidence and mortality will likely be faster among white women compared to
African American women, potentially widening disparities in cervical cancer. The challenge
is to design behavioral interventions that encourage vaccination, in particular among groups
with lower vaccine completion rates.
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Bryant and colleagues (14) developed the innovative Community-Based Participatory
Marketing (CBPM) model, which combines community-based participatory research
(CBPR) approaches with social marketing theories and methods. CBPR involves forming
collaborative community-academic partnerships for research aimed to identify community
needs and develop and test interventions to improve these problems (15,16). Incorporating
the knowledge and insights of members of the affected population in the research process
offers the potential to develop more culturally appropriate and effective interventions to
improve health outcomes and reduce disparities (17).
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The key components of social marketing are often called the “4 P’s.” The most important
“P” in social marketing is Product, including the “actual product” (the target behavior HPV vaccination) and the “core product” (the benefits of the vaccine that are attractive to
the target population and may convince a person to get it). Often the “core product” includes
perceived non-health benefits of the behavior, such as fulfilling social or emotional needs.
Price refers to real and perceived costs or barriers to engaging in the target behavior from
the consumers’ perspective and strategies to lower these costs. Placement involves where
the target audience makes decisions about getting HPV vaccine and ways to make the
service more accessible and easier to obtain. Promotion includes designing and delivering
persuasive messages to the target audience (18).
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Social marketing borrows principles and strategies from traditional marketing used in the
business sector to sell products and generate profits, and applies them to nonprofit programs
aimed at changing knowledge, attitudes or behaviors as the “product” (18–20). Social
marketing uses exchange theory, which explains that individuals make decisions about
behaviors by weighing perceived costs and benefits of their different options. In the social
marketing process, analytic techniques are used to conceptually divide the population into
distinct audiences, or market segments, that are more likely to respond to the intervention
(21). Formative research, or “audience research,” uses qualitative and/or quantitative
methods to develop the social marketing intervention plan and refine market segmentation,
with the aim of understanding people’s aspirations, values, and fears of the target population
as well as their perceptions of the benefits versus costs of the target behavior (22). Social
marketing is an effective approach for developing culturally-appropriate interventions since
it focuses on specific target audiences and emphasizes the audience’s perspective (23,24).

Our team is employing the CBPM process to develop a culturally-appropriate social
marketing intervention aimed at increasing HPV vaccine utilization among African
American adolescents. This article reports on the qualitative findings of our formative
research phase, or “audience research.” The purpose of the study was to generate
recommendations for framing messages to promote HPV vaccination for our target
audience, specifically African American adolescents and their parents who have not yet
made a decision about the vaccine (the “Undecided” market segment). Our primary research
questions related to the 4 P’s were: (1) Product – What benefits to vaccination do Undecided
parents and adolescents perceive? (2) Price – What barriers to initiating and completing
vaccination exist for the Undecided segment, and how can they be overcome? (3) Placement
– Where do parents and adolescents make decisions about HPV vaccination, and how can
the vaccine be made more accessible and easier to complete? and (4) Promotion – What
types of messages, information channels, and spokespersons may be effective for the
Undecided segment? We included both parents and daughters in the study to understand
how parents and daughters negotiate decisions regarding HPV vaccination, determine
whether parents or daughters should be the primary or secondary audience, and identify
appropriate messaging strategies for each one.
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Academic and Community Partners
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This study, affiliated with Cervical Cancer Free Tennessee, was conducted under the
Community Outreach Core (COC) of the Meharry Medical College-Vanderbilt Ingram
Cancer Center-Tennessee State University Cancer Partnership, in collaboration with the
COC’s Community Advisory Board (CAB). The CAB includes representatives from nonprofit and healthcare organizations and community members interested in cancer disparities.
The CAB has provided valuable input since the study began, including giving feedback on
focus group and interview discussion guides, assisting with subject recruitment, and
contributing to the interpretation of findings. After completing data collection, the CAB
recommended forming a Teen and Parent (TAP) committee under the CAB to work
specifically on this project, which met more frequently and was closely involved in the
interpretation of results and the subsequent development of the social marketing strategy.
Research Design
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Using a cross-sectional observational design, we collected qualitative data through focus
groups and individual interviews, using convenience sampling. Focus groups and individual
interviews are useful for formative research because they enable in-depth exploration of
complex attitudes, beliefs, and perceptions and the ability to discover unanticipated insights
(25,26). Convenience sampling is appropriate for qualitative research aimed to obtain indepth descriptive information on a relatively small sample.
Recruitment
African American girls ages 11–18 and a parent/guardian were recruited to participate in the
study. At the time the study was initiated, routine HPV vaccination was not yet
recommended for males, so the sample did not include adolescent boys. CAB members
helped to distribute flyers and electronic announcements about the study. Out of the 52
parents who made contact with the study, 28 heard about the study via email, nine through
flyers posted in community partner organizations, five through ResearchMatch.org (an
online national registry connecting researchers with people who are willing to volunteer for
studies), four from a friend, one from a doctor, and five did not report the source.
Eligibility Screening
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When parents contacted the study, study personnel screened families for eligibility over the
phone or via email based on the parent’s report of the daughter’s age (11–18 years) and race
(African American). If daughters met these criteria, the parent was asked the daughter’s
HPV vaccination status (number of shots, if any) and, if she was not vaccinated, why she
had not gotten the vaccine (either “not sure if want it or have not decided yet” or “decided
not to get it”). Then the family was assigned to one of the following four market segments,
based on the combination of daughters’ HPV vaccination status and the parent’s intent to get
the daughter vaccinated: 1) Completed – daughter received all three HPV vaccine doses, 2)
Incomplete – daughter started HPV vaccine but did not receive all three doses, 3) Undecided
– daughter not vaccinated and parent had not yet made a decision, and 4) Rejected – parent
decided not to get vaccine for daughter.
Out of the 52 parents who made contact with the study, 5 did not respond to our attempts to
screen for eligibility, and 3 were not eligible. Eligible families (N=44) were placed on a list
to invite when we were ready to schedule focus groups or interviews. We attempted to recontact and invite 39 families in order by date of recruitment, of whom 8 did not reply. The
other 5 were not re-contacted because we closed data collection due to reaching saturation of
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themes. One parent or guardian from each family was invited to take part in the study, but
only mothers decided to participate. More than one eligible daughter per family could take
part in the study. Three families had two eligible daughters to enroll, and the rest only had
one eligible daughter.
Data Collection
Data were collected, transcribed, and analyzed in an iterative process starting with two focus
groups per market segment (one for mothers and one for daughters, in separate groups),
followed by individual interviews until reaching saturation of themes for mothers and for
daughters within each market segment. Focus groups and interviews were conducted
separately for mothers and daughters and for each market segment. As reported in Table 1,
we conducted a total of eight focus groups— four with mothers, one for each market
segment (N=19 mothers), and four with daughters, one for each market segment (N=21
daughters). Each focus group included 3–7 mothers or 3–9 daughters. Next, we collected
additional individual interviews with mothers (N=12) and with daughters (N=13) from other
recruited families, conducted separately, until reaching saturation of themes within each
segment for mothers and for daughters. Individual interviews were conducted with 2–5 girls
and 2–4 mothers per market segment.
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Focus groups were moderated by two of the investigators at a local community organization,
one moderating the group with mothers and one moderating the group with daughters in
separate rooms at the same time. The same investigators subsequently conducted the
interviews with mothers on campus, while two research assistants conducted separate,
simultaneous interviews with daughters. The research assistants received a prior 90-minute
training session on the purpose of qualitative focus groups and interviews and how to
conduct them. Focus groups lasted around 90 minutes, and interviews lasted around 20–30
minutes. In the focus groups, each participant was assigned an identification number, and a
notetaker made notations of which people spoke and non-verbal communication. Focus
group and interview sessions were digitally recorded and transcribed. Each participant was
given a $30 gift card.
Discussion Guides
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With input from an external consultant expert on CBPM and from the CAB, we created
separate discussion guides for parents and daughters for each market segment (eight
different discussion guides) with open-ended questions that elicited information related to
the “4 P’s” of social marketing: product, price, placement, and promotion (18,22). The
discussion guides listed questions and possible follow-up probes to stimulate further
discussion for covering topics in a flexible manner that allowed for emergence of new ideas
(27). The discussion guides followed a “funnel structure,” which started with general, less
structured questions and moved to more specific, more structured questions (27).
Examples of key questions included, “If a friend asked you for advice about getting the
vaccine, what would you tell her? What would you say were the benefits of getting the
vaccine?” (Product), “What have you heard about the disadvantages of getting vaccinated?”
(Price), “Where did you hear about the vaccine?” (Placement), “What do you suggest as
good ways to reach African American girls to give them information about getting the
vaccine?” (Promotion). In addition, the moderator asked participants to review and react to
two sample social marketing flyers about HPV vaccine, one from the CDC and one from a
previous study (28). The majority of the discussion guides were similar across the four
market segments, with some different questions asked relevant to the daughter’s HPV
vaccination status, such as reasons for deciding to get the vaccine (Completed and
Incomplete) or not (Rejected), why they had not received all three shots (Incomplete), would
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they make the same decision again (Completed and Incomplete), or what could convince
them to get the vaccine (Undecided). The discussion guides for daughters were similar to the
discussion guides for mother, with differences in the frame of reference for the questions
(e.g., referring to daughters vs. parents) and one or two unique questions for parents or
daughters (e.g., parents: who do you trust to give you information about vaccinating your
daughter).
Data Analysis
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Four research assistants were trained during two 90 minutes sessions to code the transcript
data, including how to use Atlas.ti qualitative analysis software to create and assign codes
and extract quotes, review of the a priori themes and definitions, when and how to create
codes for new emergent themes and subthemes, and practice coding under supervision.
Based on the discussion guide and input from the consultant, investigators created a
codebook of a priori themes corresponding to specific aspects of the 4 P’s as an initial set of
codes for analysis, and then new codes were created for themes and subthemes that emerged
during analysis. Two research assistants reviewed and coded each transcript. Then, using a
negotiated agreement approach to qualitative inter-coder agreement (29), the first author
reviewed their coding for consistency and discussed with them any disagreements in coding,
in order to reconcile which final code to use. Next the quotes for each coded theme and
subtheme were extracted and reviewed again by a research assistant and the first author to
assess patterns within and across market segments and to combine or split subthemes as
needed. We also discussed preliminary findings with the TAP, which further informed
refinement of subthemes.
This process was repeated after the focus group and each individual interview for mothers
and for daughters separately within each market segment until reaching saturation of themes.
Specifically, we determined that saturation was reached for mothers or for daughters within
a segment when no new themes emerged during analysis of the transcripts. After coding was
finalized, we extracted the quotes separately for mothers and daughters for each theme and
subtheme and tallied how frequently the subthemes were mentioned by mothers or daughters
within each market segment to sort them in rank order. Then the themes and subthemes were
organized into tables separately for mothers and daughters in rank order of frequency,
indicating which market segments mentioned each one.

RESULTS
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Demographic characteristics of the sample are summarized in Table 2. The girls’ ages were
distributed across the range of 11 to 18 years (mean=14.5 years, S.D.=2.05), and the
mothers’ ages ranged from 31 to 55 years (mean=42.6 years, S.D.=5.25). All of the girls and
all but two mothers self-identified as African American. Nearly two-thirds of mothers were
married or living with a partner. While 80% had only one daughter in the age range of 11 to
18, 84% reported that they had more than one child. Although boys were not included in the
study, many of the participating parents reported that they also had male adolescent children,
and their comments often referred to both their daughters and sons.
Tables 3–6 report the themes and subthemes for each of the 4 P’s and selected illustrative
quotes. The subthemes are listed in order of how frequently they were mentioned by mothers
or by daugthers, from more frequent to less frequent. The letters in brackets indicate whether
the themes and subthemes applied to all segments or only to certain segments.
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First, we report mothers’ and daughters’ explicitly stated benefits of getting HPV vaccine
(Table 3). Both mothers and daughters mentioned the health benefits of preventing cancer
and HPV infection. Non-health benefits for mothers included protecting daughters from
harm, not wanting to regret if daughters got cancer, helping daughters realize their dreams,
and educational value. Daughters also mentioned wanting to make their own choices and
having a healthy future.
An emergent theme was the perception of HPV vaccine as different from other vaccines.
Undecided mothers who perceived HPV vaccine to be just like any other vaccination tended
to be more accepting of the vaccine. On the other hand, undecided mothers who felt HPV
vaccine was unique compared to other vaccines because it was newer and it prevented a
sexually-transmitted virus tended to be more skeptical of the vaccine. Nearly all of the
mothers felt comfortable with other routine, required vaccinations, although there was
variation in the use of the flu vaccine. Mothers had a number of aspirations for their
daughters’ future, and daughters had various professional goals for themselves. Mothers and
daughters were both concerned about daughters reaching their goals and things that could
interfere. Mothers valued teaching their daughters, watching them grow, and loving them.
Price
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During the analysis of perceived barriers, two sub-segments emerged within the Undecided
segment based on degree of reluctance to obtain the HPV vaccination. The results in Table 4
are separated for these two sub-segments. The Undecided/Ready If Offered subsegment
primarily cited lack of information, their doctor not having recommended the vaccine, or the
vaccine not being in stock at the clinic as the reasons why they had not gotten the vaccine
for their daughters, and after receiving information in the focus group, they said they were
interested in getting the vaccine. On the other hand, the Undecided/Skeptical subsegment
was open to considering HPV vaccine, but they had a variety of concerns they wanted
answered by a doctor or other reliable source before making a decision. These included
newness of the vaccine, distrust of drug companies, thinking the recommended age is too
young, lack of confidence in the vaccine’s effectiveness, concerns about side effects,
concern it could make their daughters promiscuous, thinking the vaccine is not needed, and
their daughters not being sexually active yet. Mothers in the rejected segment perceived
similar barriers, with safety/side effects the most common. Mothers in the completed and
incomplete segment generally did not perceive any barriers to initiating the HPV vaccine
series, since their daughters had already started the series.
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Many of the daughters were concerned about the pain of the injection. Girls also mentioned
being embarrassed to talk about it with their parents, thinking they did not need it because
they were not sexually active yet, doubting the effectiveness of the vaccine, concern about
side effects, and lack of information. In terms of completion of the vaccine series, mothers
mentioned the barriers of not knowing there were three shots and not knowing when they
needed to go back for the second and third shots.
Mothers suggested several strategies for overcoming these barriers. For initiation of the
vaccine, they mentioned tying HPV vaccine in with other immunizations required during
middle school and offering the vaccines at school with the parents’ consent. For completion
of the series, they suggested appointment reminders for the second and third shots (e.g., text
message, appointment card, phone message, email), allowing walk-ins for the second and
third shots, and general follow-up after the clinic visit. Some daughters suggested making a
new form of the vaccine that did not have to be administered via injection.
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Mothers primarily indicated that their decisions about HPV vaccine took place or would take
place at the doctor’s office, but some also mentioned at work for those employed in a
healthcare setting, or at home (Table 5). Daughters indicated that their parents, in particular
the mother, made or would make the decision. The level of involvement of the daughter in
the decision to vaccinate increased with age. When asked who or what would influence their
decision to get HPV vaccine for their daughters, mothers mentioned the medical provider’s
recommendation as the most important influence, along with conversations with their
daughters about the vaccine in relation to sex and sexually-transmitted infections (STI’s,
especially for older girls), hearing from other parents they know who chose to get the
vaccine, hearing about the vaccine at church, and seeing the vaccine offered together with
other pre-teen vaccines required for middle school. Some mothers felt HPV vaccine should
be mandatory like other vaccines, while others were not comfortable with it being
mandatory. Daughters mentioned their decisions would be influenced by receiving
information about the vaccine at school, through wellness classes or materials sent home to
parents, the medical provider’s recommendation, and hearing from peers who have gotten
the vaccine.
Promotion
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Mothers and daughters suggested multiple information channels to disseminate messages
promoting the vaccine, including mass media, in-person events, the doctor’s office,
community organizations, school, social media, text messaging, and videos (Table 6).
Daughters mentioned technology-based strategies more often than mothers. For effective
spokespersons, both mothers and daughters mentioned doctors, famous celebrities, and
persons who have had HPV, cancer, or the vaccine. Mothers also mentioned media
personalities and community organizations, and daughters mentioned public health
authorities and other teenagers. Mothers suggested messages should provide general
information about HPV vaccine, recommend it together with other pre-teen vaccines, come
from a trusted source, provide information about safety and side effects, cite figures on
cancer and mortality, indicate recommended ages for vaccination, include both boys and
girls, be directed to both parents and teens, explain how HPV is spread, and direct them
where to get more information. They also said messages should be simple and include a
catchy slogan or tune. Daughters suggested messages should be eye-catching with colorful
text and images, and messages for teenagers should be made by and/or designed especially
for teenagers. They said messages should include information about safety and side effects
of the vaccine and about how common HPV infection is.
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DISCUSSION
We stratified our sample by four market segments based on HPV vaccination status and
intent to vaccinate, in order to compare the Undecided segment to those who had already
vaccinated or had rejected the vaccine and, thus, identify social marketing strategies specific
to our target group, the Undecided segment. During data analysis, we identified two
subsegments within the Undecided segment based on barriers to vaccination and degree of
reluctance. These segments and sub-segments – Completed, Incomplete, Undecided/Ready
If Offered, Undecided/Skeptical, and Rejected – reflect the pattern of vaccine dissemination
from early adopters to laggards in the Dissemination of Innovations Theory (13). Our
formative research findings suggested several ways in which a social marketing campaign
for HPV vaccination could be targeted for Undecided African American adolescents and
their mothers.
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The findings related to Product suggest that HPV vaccine should be presented to the
Undecided segment as a routine vaccine (just like other vaccines) that helps prevent cancer.
We recommend framing the core product for Undecided African American mothers as:
Getting HPV vaccine is a way to protect your children from harm, help them to realize their
dreams, and avoid future regret if your children were to develop cancer. For Undecided
African American girls, we recommend framing the core product as: Getting HPV vaccine is
a way to feel empowered to take charge of your health and have a healthy future to realize
all of your dreams. A study that pre-tested social marketing messages in a multi-ethnic rural
sample found that mothers preferred messages appealing to their instinct to protect their
daughters from harm and their aspirations for their daughters’ future (30). In a multi-ethnic
survey of parents, anticipated regret was associated with vaccination (31). A survey of
African American parents reported preventing cancer, protecting daughters from harm, and
reducing worries about future health as important reasons to vaccinate daughters (32).
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Findings related to Price suggest that the Undecided/Ready If Offered segment would easily
accept getting HPV vaccine if given the opportunity; they just needed basic information and
a doctor recommendation. The Undecided/Skeptical segment would need more in-depth
information to allay their concerns about vaccine safety, mistrust of drug companies, and to
explain why adolescents need the vaccine at an early age before becoming sexually active.
Some mothers and girls had the erroneous perception that girls do not need the vaccine until
they become sexually active. Concerns about the recommended vaccination age and
daughters not being sexually active were also identified by African American parents in
other studies as barriers to HPV vaccination (31–33). A multi-ethnic focus group study
found that mistrust of drug companies was stronger among African American parents than in
other racial/ethnic groups (34), who made references to the Tuskegee syphilis study (35).
African American girls and their mothers overwhelmingly thought campaigns should target
both girls and boys for HPV vaccination. Many of the mothers had both daughters and sons
and wanted to receive information relevant to all of their children, since the vaccine is now
approved for boys and HPV causes other cancers besides cervical cancer. Two recent studies
reported that the majority of African American or ethnically-diverse parents support getting
HPV vaccine for their sons (36,37). Future research should investigate the effectiveness of
promoting HPV vaccine for both girls and boys.
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Some mothers were comfortable talking about STI’s with their daughters, while other
mothers did not like messages that linked HPV vaccine to sexual activity because their
daughters were too young to be thinking about sex yet or they did not feel comfortable
talking about it with them. A few mothers were concerned that the vaccine could cause girls
to feel protected against STIs and encourage sexual activity. Other studies have also found
this perception among some parents (38). Campaigns and messages may need to be tailored
for pre-teens versus teens and their parents, with less emphasis on HPV as an STI for
younger ages. At the same time, nearly all mothers and adolescents perceived cancer
prevention as a major benefit of the vaccine, so it may be more effective for campaigns to
emphasize cancer prevention over STI prevention. Another study testing social marketing
messages about HPV vaccine also found that mothers preferred messages about preventing
cervical cancer rather than messages about preventing HPV (30). In addition, parents likely
need to be the primary audience when targeting pre-teens since they tend to make the
vaccine decision, while older teens may be more involved in the decision and could be either
the primary or secondary audience.
Limitations
The study relied on parents’ self-report of their daughters’ vaccination status, which can be
affected by recall bias (44). Parents’ self-report of vaccination status and participants’
Gynecol Oncol. Author manuscript; available in PMC 2015 March 01.
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comments during focus groups and interviews could also be influenced by social
desirability, meaning the desire to present favorably in front of researchers or peers. In
addition, convenience samples are potentially limited by selection bias.
Significance
This study makes several contributions to HPV vaccine literature. First, very little social
marketing research focusing on HPV vaccine has been published to date (28,30). This is the
first published study to identify specific market segments related to HPV vaccine and to
report on formative qualitative data aimed at comparing the Undecided segment to those
who have received or rejected the vaccine. Second, while several studies examine attitudes
about HPV vaccine and correlates of HPV vaccination, and several include a substantial
proportion of African Americans in the sample (34,31,39,36,40), few focus on both African
American adolescent females and mothers, as this study does (41–43,32). Finally, this study
provides valuable formative data that can inform the development of social marketing
campaigns to increase HPV vaccination that target African American or ethnically diverse
adolescents and their parents in the Undecided segment.
Conclusion

NIH-PA Author Manuscript

Increasing uptake and completion of the HPV vaccine series among African American girls
will reduce rates of cervical cancer among African American women, which in combination
with continued Pap testing can eventually reduce disparities in cervical cancer. Overall, our
findings pointed to the need to “normalize” the perception of HPV vaccine as just another
routine vaccine. Mothers wanted HPV vaccine promoted for both boys and girls, rather than
singling out only girls. Many mothers wanted HPV vaccine promoted together with other
vaccines that are recommended for pre-teens, instead of singling out HPV vaccine.
Undecided mothers who felt HPV vaccine was different from other vaccines tended to be
more skeptical of the vaccine. These formative research findings may be informative for the
development of social marketing interventions promoting HPV vaccine among Undecided
parents and adolescents.
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RESEARCH HIGHLIGHTS
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•

Skeptical mothers need in-depth information about vaccine safety and age
recommendations to accept the vaccine.

•

Mothers suggested promoting HPV vaccine together with other pre-teen
vaccines, targeting both boys and girls, and emphasizing cancer prevention.

•

Findings suggest need to “normalize” perception of HPV vaccine as a routine
vaccine rather than singling it out as unique.
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Table 1

Number of Participants by Eligibility Category
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# of Participants
Eligibility Category/Market Segments

Focus Groups

Individual Interviews

1.a. Girls

6

5

1.b. Mothers

6

4

Category 1: Completed vaccine series

Category 2: Incomplete: Started/did not complete series
2.a. Girls

3

2

2.b. Mothers

3

2

3.a. Girls

3

2

3.b. Mothers

3

2

4.a. Girls

9

4

4.b. Mothers

7

4

40

25

Category 3: Not vaccinated – Rejected vaccine

Category 4: Not vaccinated – Undecided
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Total number of participants
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Table 2

Demographic Characteristics of Mothers and Daughters in Sample

NIH-PA Author Manuscript

Variable

N

%

Daughter’s Age
11

2

5.9

12

5

14.7

13

5

14.7

14

6

17.6

15

4

11.8

16

6

17.6

17

3

8.8

18

3

8.8

2

6.5

36–39 years

7

22.6

40–44 years

12

38.7

45 and older

10

32.2

African American

28

90.3

Other

3

9.7

Never married

5

16.1

Divorced

6

19.4

Living with a partner

2

6.5

Married

18

58.1

Mother’s Age
30–35 years

NIH-PA Author Manuscript

Mother’s Race

Marital Status

Completed degree
Less than high school degree

1

3.2

High school degree/GED

18

58.1

Bachelor’s Degree

5

16.1

Graduate Degree

7

22.6

1

5

16.1

2

9

29.0

3

9

29.0

4

6

19.4

5

2

6.5

1

25

80.6

2

3

9.7

3

3

9.7

Number of children
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Number of daughters between the ages of 11 and 18

Gynecol Oncol. Author manuscript; available in PMC 2015 March 01.

Hull et al.

Page 16

Table 3

Summary of Findings for Product: Benefits of Getting HPV Vaccine
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MOTHERS
Benefits of vaccinating [A]
•

Prevents cancer

•

Prevents HPV/STIs (no cure for HPV)

•

Protects daughter from harm

•

Don’t want to regret it if she gets cancer

•

Realize her dreams

•

Educational value for daughter

“I think it’s a really good preventative measure for girls and boys.”
[C]
“…there is a potential that she could, being young, unknowingly be
infected with the HPV virus because you can’t look at someone and
tell that they have the virus and so rather than taking that risk to just
go ahead and get it [vaccine].” [C]
“…if you can get a vaccine to prevent something, then I think it’s a
good idea, because there’s not many vaccines out there that can
prevent sexually transmitted-type viruses.” [C]
Comparison with other vaccines

NIH-PA Author Manuscript

•

Family receives other vaccines [C, U]

•

Just like any other vaccination [U]

•

Similar to flu shot [C]

•

Some see it as different because newer and associated
with sexual activity [U]

“…it is a much more valuable vaccination than the flu.
I’m going to get over the flu. HPV is potentially something I can have
for a lifetime.” [C]
“…they get chicken pox shots and measles shots and the hepatitis
shot. Why don’t they get this one?” [U]
“I just tried to put it in the view of she’s had all the other childhood
immunizations.” [C]

Aspirations for Daughters
•

That daughter is a well-rounded, balanced, focused,
confident individual [U]

•

That she remembers what she was taught [U]

•

That she is responsible [A]

•

That she is a productive member of society [C]

“…remember who she is and to stay grounded even during those
times when her life is pulling her in different directions.” [U]
Values
•

Teaching daughter [U]

•

Leading by example [U]

•

Watching her grow [A]

•

Showing her love and affection [A]

•

Learning from her [C]

“I just want my daughter to literally not make some of the mistakes
that I did…” [U]
Concerns for Daughter
•

Her future/Reaching her goals [U]

•

Boys/Sex/Getting pregnant/STIs [A]

•

Health [A]

•

Peer pressures [A]

•

Self-awareness/Confidence [A]

•

That she makes good choices [A]

•

School [A]

•

That she learns from my mistakes [A]

•

Appearance [A]

•

Emotional health [C]

•

Keep her safe/protected [C]

“One of the things I want for my daughter do is to remain confident in
is her ability to lead and I don’t want her to get caught up in being a
follower.” [R]

NIH-PA Author Manuscript

DAUGHTERS
Benefits of vaccinating [A]

Concerns for Self [A]

•

Prevents cancer

•

Reaching goals/getting a good job

•

Protects myself in general

•

Getting into college/making good grades

•

Prevents HPV

•

Buying a car/learning to drive

•

To make my own choices

•

Family issues

•

Have a healthy future

Aspirations for Self [A]
•

To work in the medical field

•

To work in the fashion industry

•

To be a teacher

“I wonder about what people think of me when I walk into a room…”
[I]
“I try to look for a boy to replace my real father because my real
father, he’s not really there for me like I wish he was and I want
somebody to be there for me…” [U]
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MOTHERS
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•

To attend & graduate college

•

To own my own business

“My dream is to become a nurse because I like helping people and
children…” [U]
Note: Subthemes in bulleted lists are listed in order of frequency, from more frequent to less frequent.
Key: Letters in brackets indicate to which market segment each theme/subtheme applies, as follows: A= All segments, C= Completed, I=
Incomplete, U= Undecided, R= Rejected.
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Table 4

Summary of Findings for Price: Costs/barriers to starting and completing vaccine

NIH-PA Author Manuscript

MOTHERS
Barriers to starting vaccination series
Undecided [U] – Ready if Offered segment:
•

Do not know enough about it

•

Doctor has not recommended it

•

Vaccine not in stock at clinic

“Her doctor never said for her to get the shot or the vaccine, and that
concerns me because she goes every year and nobody mentioned it.” [U]
Undecided [U] – Skeptical segment:
•

Vaccine is too new

•

Distrust of drug companies

•

Recommended age too young

•

No guarantee the vaccine works

•

Concern about side effects

NIH-PA Author Manuscript

•

May make daughter promiscuous

•

Vaccine not necessary

•

Daughter is not sexually active

Barriers to completing the vaccination series [I, U, R]
•

Not knowing there were 3 shots

•

Not sure when next appointment/shot was due

“…there is second shot, that was the one thing I was not
aware of…” [R]
Ways to overcome barriers [I, C]
•

Appointment reminders (text, card, phone
message, email)

•

Allow walk-ins for 2nd and 3rd shots rather than
appointment

•

Tie in with other school immunizations

•

Offer the vaccine at school

•

Follow-up after clinic visit

“I wish it could tie in with other immunizations.” [C]
“…my life is so busy and trying to remember everything, a
phone call, a text, an email, any kind of reminder…” [I]

“…it’s not even really the vaccine so much. I think it’s just the idea of me
thinking about my daughter being sexually active. I think if I was able to grasp
that more, I would probably be more flexible.” [U]
Rejected [R] segment:
•

Concern about side effects

•

Do not know enough about it

•

No guarantee the vaccine works

•

Vaccine is too new

•

Daughter is not sexually active

“…I felt like it was a relatively new vaccine and I didn’t want her to be used as
kind of a guinea pig.” [R]
DAUGHTERS
Barriers to starting vaccination series
Undecided [U] segment:

NIH-PA Author Manuscript

•

Pain/scared of shots

•

Embarrassed to talk about it with parents

•

Not sexually active so do not need it

•

Vaccine may not work

•

Concern about side effects

•

Do not know enough about it

Rejected [R] segment:
•

Concern about side effects

•

Pain

•

Do not know enough about it

•

Not sexually active so do not need it

Ways to overcome barriers [U, I]
•

Give vaccine in form other than injection

•

Give rewards for getting vaccinated

“… it would be an awkward conversation because your parents would be like,
‘well how do you feel about doing this or are you doing this?’, and some
questions get irritating after a while.” [U]
Note: Subthemes in bulleted lists are listed in order of frequency, from more frequent to less frequent.
Key: Letters in brackets indicate to which market segment each theme/subtheme applies, as follows: A= All segments, C= Completed, I=
Incomplete, U= Undecided, R= Rejected.
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Table 5

Summary of Findings for Placement
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MOTHERS
Decision Location [C, R, I]

Decision Influencers

•

At the clinic/doctor’s office

•

Medical provider recommendation [A]

•

At work in a healthcare setting

•

Parent/daughter conversation (about sex, STIs, etc.) [A]

•

At home

•

Communication with other parents [C]

•

Church (completed group) [C]

•

Recommend with other pre-teen vaccines required for school
[C]

•

Make vaccine mandatory [C]

•

Some would be uncomfortable with mandate [U]

“It was time for my daughter’s yearly, along with her going to
the seventh grade this year…” [I]
“…when I first found out about the information I came home
with the information and I gave it to her to read and I also read
it, we read it together and she asked me any questions about it
because I made sure that I knew before I gave information to
her.” [C]

“For me it would be my gynecologist, I trust him a lot. But I’m still kind of
skeptical, so it would be a combination between what he said, his opinion,
and what I read…” [U]
“I would find out at each church who are the parents whose children have
had it…” [C]
DAUGHTERS

NIH-PA Author Manuscript

Decision Location [A]
•

Decision Influencers [A]

Parents (mom) make decision

“One of my brother’s friends, she got cervical cancer, and we
were talking about that before we went to the doctor’s office, so
my mom asked my doctor if I could get it.” [C]
“My mom said I’m not going to get it. She doesn’t want me to.”
[R]

•

School – wellness class and information sent home

•

Medical provider recommendation

•

Communication with peers

“…she talked to my pediatrician and he said his daughter had it. So my
mom was like, “well, if he said its ok, then its ok. Because he’s known me
since I was born…” [C]

Note: Subthemes in bulleted lists are listed in order of frequency, from more frequent to less frequent.
Key: Letters in brackets indicate to which market segment each theme/subtheme applies, as follows: A= All segments, C= Completed, I=
Incomplete, U= Undecided, R= Rejected.
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Table 6

Summary of Findings for Promotion
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MOTHERS
Informational Channels [A]

Message Design Recommendations [A]

•

Radio

•

General information about vaccine

•

Informational forum/event

•

Message from trusted source

•

Doctor’s office

•

Recommend together with other preteen vaccines

•

Community organizations/church

•

Information about safety/side effects

•

Social media (Twitter, Facebook)

•

Statistics on cancer and mortality

•

Internet web sites

•

Clarify recommended ages

•

Text messaging

•

Include information for boys and girls

•

YouTube/video

•

Directed to both parents and teens

•

Television

•

Information about how HPV is contracted

•

Flyer

•

Where/how to find more information

•

School

•

Keep it simple

•

Catchy slogan/tune

NIH-PA Author Manuscript

“…any type of youth event, youth rally, youth conventions.” [C]
“…with the age that you’re looking at, I mean most of them talk,
text, tweet, Facebook.” [I]
Effective Spokespersons [A]
•

Doctor

•

Famous celebrity

•

Someone who had HPV/cancer/vaccine

•

Radio/TV host

•

Community organization (e.g., Boys & Girls Club,
Girl Scouts)

“…boys need to know about it too. I mean especially if they are doing
these things, they are having sexual contact with people, and boys start a
little bit quicker than girls sometimes.” [U]
“…it would just have to be that over time I would just have to hear how
many people did it actually prevent from catching cervical cancer. Tell
me, show me the outcome of it.” [R]

“…maybe somebody like a lot of people would look up to, a lot of
kids look up to the radio station host.” [I]
“Realistic stories. Realistic stories. Real things that happen to real
people.” [R]
DAUGHTERS
Informational Channels [A]

Effective Spokespersons [A]

NIH-PA Author Manuscript

•

Social media

•

Famous celebrity

•

Flyers

•

Public health authority (e.g., health dept., CDC)

•

Internet web sites

•

Doctor

•

School

•

Someone who had HPV/cancer

•

Text messaging

•

Other teenagers

•

YouTube/video

•

Smartphone App

•

Church

“…because a lot of us have iPods, iPhones, phones period. So they
know that’s just in their pocket if they need information or have
questions.” [R]
“…the way I find out things is always, always through school and
Tumblr, which is a social networking site.” [C]

“…if they see somebody else that is their age and they are talking about
it and they have gotten it, then it will probably be more effective.” [R]
Message Design Recommendations [A]
•

Colorful with bold letters and pictures

•

Information about safety/side effects

•

Information made by/directed to teenagers

•

Information about how common HPV is

Note: Subthemes in bulleted lists are listed in order of frequency, from more frequent to less frequent.
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Key: Letters in brackets indicate to which market segment each theme/subtheme applies, as follows: A= All segments, C= Completed, I=
Incomplete, U= Undecided, R= Rejected.
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